Ivabradina, insufficienza cardiaca e malattia renale cronica

Giovanni Barbera; Alberto Santoboni; Antonio De Pascalis; Rodolfo Rivera; Fulvio Floccari; Claudio Ronco; Luca Di Lullo

doi:10.33393/gcnd.2015.808

Ivabradine, heart failure and chronic kidney disease

Authors

Giovanni Barbera U.O.C. Nefrologia e Dialisi, Ospedale L. Parodi-Delfino, Colleferro (RM)
Alberto Santoboni U.O.C. Nefrologia e Dialisi, Ospedale L. Parodi-Delfino, Colleferro (RM)
Antonio De Pascalis U.O.C. Nefrologia, Dialisi e Trapianto, Ospedale V. Fazzi, Lecce
Rodolfo Rivera U.O.C. Clinica Nefrologica, Ospedale S. Gerardo, Monza (MB)
Fulvio Floccari U.O.C. Nefrologia e Dialisi, Ospedale S. Paolo, Civitavecchia (RM)
Claudio Ronco International Renal Research Institute, Ospedale S. Bortolo, Vicenza
Luca Di Lullo U.O.C. Nefrologia e Dialisi, Ospedale L. Parodi-Delfino, Colleferro (RM)

DOI:

https://doi.org/10.33393/gcnd.2015.808

Keywords:

Heart failure, Comorbidities, Ivabradine, SHIFT trial, Morbidity, Mortality, Hospitalizations, Ventricular remodelling, Beta-blockers

Abstract

Ivabradine, heart failure and chronic kidney disease Incidence and prevalence of congestive heart failure are raising, especially in western countries. In Europe and in the United States it represents a disabling clinical disease for all injured people and it's accountable for the increase of hospitalization and sanitary costs. European guidelines have underlined the importance of the optimization of pharmacological treatment to improve both patients' outcomes and quality of life. SHIFT trial's results, based on the evaluation of ivabradine's efficacy if added to conventional congestive heart failure's therapy, seem to proceed in that direction. (Cardionephrology)

Downloads

Download data is not yet available.

Downloads

PDF (Italiano)

Published

2015-06-05

How to Cite

Barbera, G., Santoboni, A., De Pascalis, A., Rivera, R., Floccari, F., Ronco, C., & Di Lullo, L. (2015). Ivabradine, heart failure and chronic kidney disease. Giornale Di Clinica Nefrologica E Dialisi, 27(2), 119–124. https://doi.org/10.33393/gcnd.2015.808

Download Citation

Issue

Vol. 27 No. 2 (2015): April-June 2015

Section

Cardionephrology

License

Authors contributing to Giornale di Clinica Nefrologica e Dialisi (GCND) agree to publish their articles under the CC-BY-NC 4.0 license, which allows third parties to re-use the work without permission as long as the work is properly referenced and the use is non-commercial.